Watchlist Price Alert

Ocuphire Pharma Inc. (OCUP)

NASDAQ: OCUP · Real-Time Price · USD

1.17

-0.16 (-12.03%)

At close: Oct 23, 2024, 10:00 PM

Ocuphire Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	30.32M	50.5M	42.63M	24.53M	16.4M	1.54M	8.74M	8.9M	11.58M
Short-Term Investments	2K	15K	49K	219K	n/a	3M	5.98M	17.93M	8.74M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-636K	-10K	-14K	n/a	30.79K	30.78K	30.78K
Receivables	5.77M	2.33M	4.85M	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	95K	n/a	n/a	n/a
Other Current Assets	515K	102K	80K	71K	26K	206K	1.17M	1.3M	429.04K
Total Current Assets	36.61M	53.95M	48.99M	26.07M	17.67M	1.76M	15.9M	28.14M	20.92M
Property-Plant & Equipment	252K	n/a	6K	10K	14K	22K	112.47K	121.46K	88.65K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	252K	n/a	6K	10K	14K	22K	143.26K	152.24K	119.43K
Total Assets	36.86M	53.95M	48.99M	26.08M	17.68M	1.78M	16.04M	28.29M	21.04M
Account Payables	3.15M	2.15M	1.07M	1.58M	1.21M	342K	547.52K	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	621K	-1.34M	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	538K	n/a	5.67M	n/a	n/a	n/a
Other Current Liabilities	8.15M	1.14M	902K	1.25M	1.65M	2.71M	2.51M	3.23M	1.88M
Total Current Liabilities	11.29M	4.04M	2.75M	3.85M	3.19M	9.34M	3.15M	3.23M	1.88M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	63.6K	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-636K	n/a	27.96M	-63.6K	2.33M	7.91M	1.65M
Total Long-Term Liabilities	n/a	n/a	1.07M	n/a	27.96M	105.32K	2.33M	8.29M	2.1M
Total Liabilities	11.29M	4.04M	2.75M	3.85M	31.15M	9.34M	5.48M	11.52M	3.99M
Total Debt	n/a	n/a	n/a	538K	n/a	5.67M	1.34M	n/a	n/a
Common Stock	3K	2K	2K	2K	1K	402.00	3.75K	3.17K	23.74K
Retained Earnings	-139M	-81.47M	-71.48M	-89.37M	-32.67M	-8.05M	-154.69M	-140.32M	-115.02M
Comprehensive Income	n/a	-0.00	n/a	n/a	n/a	2.08K	-17.84K	-56.89K	-6.12K
Shareholders Equity	6.72M	49.91M	46.24M	22.22M	-13.47M	-7.56M	10.56M	16.77M	17.06M
Total Investments	n/a	15K	49K	219K	n/a	3M	5.98M	17.93M	8.74M